Minimal inhibitory concentrations and minimal bactericidal concentrations of quinupristin/dalfopristin against clinical isolates of Corynebacterium jeikeium and Listeria monocytogenes

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue SUPPL. A, 1997, Pages 67-68

  Moore, Lynn Steele ^a   Schneider, Barbara ^a   Holloway, William J ^a  

^a MEDICAL CENTER OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN; QUINUPRISTIN; STREPTOGRAMIN DERIVATIVE;

ARTICLE; BACTERIOSTASIS; CORYNEBACTERIUM; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0030965384     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.suppl_1.67     Document Type: Article

References (14)

1. Brumfltt, W., Hamilton-Miller, J. M. T. & Shah, S. (1992). In-vitro activity of RP 59500, a new semisynthetic streptogramin, against Gram-positive bacteria. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 29-37.
2. Fremaux, A., Sissia, G., Cohen, R. & Geslin, P. (1992). In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 19-23.
3. Goto, S., Miyazaki, S. & Kaneko, Y. (1992). The in-vitro activity of RP 59500 against Gram-positive cocci. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 25-8.
4. Inoue, M., Okamoto, R., Okubo, T., Inoue, K. & Mitsuhasi, S. (1992). Comparative in-vitro activity of RP 59500 against clinical isolates. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 45-51.
5. Pechère, J. C. (1992). In-vitro activity of RP 59500, a semi-synthetic streptogramin, against staphylococci and streptococci. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 15-8.
6. Soussy, C. J., Acar, J. F., Cluzel, R., Courvalin, P., Duval, J., Fleurette, J. et al. (1992). A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 53-8.
7. Aumercier, M., Bouhallab, S., Capmau, M.-L. & Le Goffic, F. (1992). RP 59500: a proposed mechanism for its bactericidal activity. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 9-14.
8. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically - Third Edition. Approved Standard M7-A3. NCCLS, Villanova, PA.
9. Deresinski, S. (1992). Listeriosis in normal and immunocompromised hosts. Infectious Disease Alert II (16), 101-4.
10. Finegold, S. M. & Baron, E. J. (1994). Aerobic, nonspore-forming, Gram-positive bacilli. In Bailey & Scotts Diagnostic Microbiology, 9th edn (Finegold, S. M. & Baron E. J., Eds), pp. 457-62. C. V. Mosby Co., St Louis, MO.
11. Baquero, F. (1995). Gram-positive resistance: a challenge for the development of new antibiotics. In Program and Abstracts of the Nineteenth International Congress of Chemotherapy, Montreal, 1995. Canadian Journal of Infectious Diseases 6, Suppl. C, Abstract 0290, p. 231C.
12. Donnelly, P. J. (1995). Bacterial complications of transplantation: diagnosis and treatment. Journal of Antimicrobial Chemotherapy 36, Suppl. B, 59-72.
13. Neu, H. C., Chin, N. & Gu, J. (1992). The in-vitro activity of new streptogramins, RP59500, RP57669 and RP54476, alone and in combination. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 83-94.
14. Nichterlein, T. & Kretschmar, M. (1995). RP 59500 is effective in murine listeriosis. In Proceedings of the Seventh European Congress of Clinical Microbiology and Infectious Diseases, Vienna, 1995. Abstract 778, p. 151.